Literature DB >> 9737924

Shared receptor components but distinct complexes for alpha and beta interferons.

M Lewerenz1, K E Mogensen, G Uzé.   

Abstract

The type I interferon family includes 13 alpha, one omega and one beta subtypes recognized by a complex containing the receptor subunits ifnar1 and ifnar2 and their associated Janus tyrosine kinases, Tyk2 and Jak1. To investigate the reported differences in the way that alpha and beta interferons signal through the receptor, we introduced alanine-substitutions in the ifnar2 extracellular domain, and expressed the mutants in U5A cells, lacking endogenous ifnar2. A selection, designed to recover mutants that responded preferentially to alpha or beta interferon yielded three groups: I, neutral; II, sensitive to alpha interferon, partially resistant to beta interferon; III, resistant to alpha interferon, partially sensitive to beta interferon. A mutant clone, TMK, fully resistant to alpha interferon with good sensitivity to beta interferon, was characterized in detail and compared with U5A cells complemented with wild-type ifnar2 and also with Tyk2-deficient 11.1 cells, which exhibit a similar alpha-unresponsive phenotype with a partial beta interferon response. Using anti-receptor antibodies and mutant forms of beta interferon, three distinct modes of ligand interaction could be discerned: (i) alpha interferon with ifnar1 and ifnar2; (ii) beta interferon with ifnar1 and ifnar2; (iii) beta interferon with ifnar2 alone. We conclude that alpha and beta interferons signal differently through their receptors because the two ligand subtypes interact with the receptor subunits ifnar 1 and ifnar2 in entirely different ways. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9737924     DOI: 10.1006/jmbi.1998.2026

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  26 in total

1.  Characterization of a soluble ternary complex formed between human interferon-beta-1a and its receptor chains.

Authors:  R M Arduini; K L Strauch; L A Runkel; M M Carlson; X Hronowski; S F Foley; C N Young; W Cheng; P S Hochman; D P Baker
Journal:  Protein Sci       Date:  1999-09       Impact factor: 6.725

2.  Structure of the interferon-receptor complex determined by distance constraints from double-mutant cycles and flexible docking.

Authors:  L C Roisman; J Piehler; J Y Trosset; H A Scheraga; G Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-11-06       Impact factor: 11.205

3.  Cytokine Activation by Antibody Fragments Targeted to Cytokine-Receptor Signaling Complexes.

Authors:  Srilalitha Kuruganti; Shane Miersch; Ashlesha Deshpande; Jeffrey A Speir; Bethany D Harris; Jill M Schriewer; R Mark L Buller; Sachdev S Sidhu; Mark R Walter
Journal:  J Biol Chem       Date:  2015-11-06       Impact factor: 5.157

4.  Receptor density is key to the alpha2/beta interferon differential activities.

Authors:  Ignacio Moraga; Daniel Harari; Gideon Schreiber; Gilles Uzé; Sandra Pellegrini
Journal:  Mol Cell Biol       Date:  2009-06-29       Impact factor: 4.272

Review 5.  Cytokines in immune function and sleep regulation.

Authors:  James M Krueger; Jeannine A Majde; David M Rector
Journal:  Handb Clin Neurol       Date:  2011

6.  Interferon-alpha and -beta differentially regulate osteoclastogenesis: role of differential induction of chemokine CXCL11 expression.

Authors:  Luiz F Leomil Coelho; Gabriel Magno de Freitas Almeida; Franck J D Mennechet; Anne Blangy; Gilles Uzé
Journal:  Proc Natl Acad Sci U S A       Date:  2005-08-04       Impact factor: 11.205

7.  The Interferon-Inducible Proteoglycan Testican-2/SPOCK2 Functions as a Protective Barrier against Virus Infection of Lung Epithelial Cells.

Authors:  Narae Ahn; Woo-Jong Kim; Nari Kim; Han Wook Park; Seung-Woo Lee; Joo-Yeon Yoo
Journal:  J Virol       Date:  2019-09-30       Impact factor: 5.103

8.  Kinetic analysis of cytokine-mediated receptor assembly using engineered FC heterodimers.

Authors:  Ashlesha Deshpande; Balananda-Dhurjati Kumar Putcha; Srilalitha Kuruganti; Mark R Walter
Journal:  Protein Sci       Date:  2013-06-06       Impact factor: 6.725

9.  The tyrosine kinase Tyk2 controls IFNAR1 cell surface expression.

Authors:  Josiane Ragimbeau; Elisabetta Dondi; Andrés Alcover; Pierre Eid; Gilles Uzé; Sandra Pellegrini
Journal:  EMBO J       Date:  2003-02-03       Impact factor: 11.598

10.  TCDD-mediated suppression of the in vitro anti-sheep erythrocyte IgM antibody forming cell response is reversed by interferon-gamma.

Authors:  Colin M North; Byung-Sam Kim; Neil Snyder; Robert B Crawford; Michael P Holsapple; Norbert E Kaminski
Journal:  Toxicol Sci       Date:  2008-10-22       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.